Global CAR-T Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global CAR-T Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the CAR-T Drugs industry chain, the market status of Hematoma (CD19 CAR-T, BCMACAR-T), Solid Tumors (CD19 CAR-T, BCMACAR-T), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CAR-T Drugs.
Regionally, the report analyzes the CAR-T Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CAR-T Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CAR-T Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CAR-T Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., CD19 CAR-T, BCMACAR-T).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CAR-T Drugs market.
Regional Analysis: The report involves examining the CAR-T Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CAR-T Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CAR-T Drugs:
Company Analysis: Report covers individual CAR-T Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CAR-T Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hematoma, Solid Tumors).
Technology Analysis: Report covers specific technologies relevant to CAR-T Drugs. It assesses the current state, advancements, and potential future developments in CAR-T Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CAR-T Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CAR-T Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe CAR-T Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CAR-T Drugs, with price, sales, revenue and global market share of CAR-T Drugs from 2018 to 2023.
Chapter 3, the CAR-T Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CAR-T Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and CAR-T Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of CAR-T Drugs.
Chapter 14 and 15, to describe CAR-T Drugs sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the CAR-T Drugs industry chain, the market status of Hematoma (CD19 CAR-T, BCMACAR-T), Solid Tumors (CD19 CAR-T, BCMACAR-T), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CAR-T Drugs.
Regionally, the report analyzes the CAR-T Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CAR-T Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CAR-T Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CAR-T Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., CD19 CAR-T, BCMACAR-T).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CAR-T Drugs market.
Regional Analysis: The report involves examining the CAR-T Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CAR-T Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CAR-T Drugs:
Company Analysis: Report covers individual CAR-T Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CAR-T Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hematoma, Solid Tumors).
Technology Analysis: Report covers specific technologies relevant to CAR-T Drugs. It assesses the current state, advancements, and potential future developments in CAR-T Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CAR-T Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CAR-T Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- CD19 CAR-T
- BCMACAR-T
- Others
- Hematoma
- Solid Tumors
- Others
- Novartis
- Gilead Sciences
- WuXi Biologics
- Sanofi
- Juno Therapeutics
- Bluebird Bio
- Cellectis
- Precision Biosciences
- CRISPR Therapeutics
- Autolus Therapeutics
- Adaptimmune Therapeutics
- Atara Biotherapeutics
- Tmunity Therapeutics
- Iovance Biotherapeutics
- Celyad Oncology
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe CAR-T Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CAR-T Drugs, with price, sales, revenue and global market share of CAR-T Drugs from 2018 to 2023.
Chapter 3, the CAR-T Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CAR-T Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and CAR-T Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of CAR-T Drugs.
Chapter 14 and 15, to describe CAR-T Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of CAR-T Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global CAR-T Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 CD19 CAR-T
1.3.3 BCMACAR-T
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global CAR-T Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hematoma
1.4.3 Solid Tumors
1.4.4 Others
1.5 Global CAR-T Drugs Market Size & Forecast
1.5.1 Global CAR-T Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global CAR-T Drugs Sales Quantity (2018-2029)
1.5.3 Global CAR-T Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis CAR-T Drugs Product and Services
2.1.4 Novartis CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR-T Drugs Product and Services
2.2.4 Gilead Sciences CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences Recent Developments/Updates
2.3 WuXi Biologics
2.3.1 WuXi Biologics Details
2.3.2 WuXi Biologics Major Business
2.3.3 WuXi Biologics CAR-T Drugs Product and Services
2.3.4 WuXi Biologics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 WuXi Biologics Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi CAR-T Drugs Product and Services
2.4.4 Sanofi CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi Recent Developments/Updates
2.5 Juno Therapeutics
2.5.1 Juno Therapeutics Details
2.5.2 Juno Therapeutics Major Business
2.5.3 Juno Therapeutics CAR-T Drugs Product and Services
2.5.4 Juno Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Juno Therapeutics Recent Developments/Updates
2.6 Bluebird Bio
2.6.1 Bluebird Bio Details
2.6.2 Bluebird Bio Major Business
2.6.3 Bluebird Bio CAR-T Drugs Product and Services
2.6.4 Bluebird Bio CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bluebird Bio Recent Developments/Updates
2.7 Cellectis
2.7.1 Cellectis Details
2.7.2 Cellectis Major Business
2.7.3 Cellectis CAR-T Drugs Product and Services
2.7.4 Cellectis CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cellectis Recent Developments/Updates
2.8 Precision Biosciences
2.8.1 Precision Biosciences Details
2.8.2 Precision Biosciences Major Business
2.8.3 Precision Biosciences CAR-T Drugs Product and Services
2.8.4 Precision Biosciences CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Precision Biosciences Recent Developments/Updates
2.9 CRISPR Therapeutics
2.9.1 CRISPR Therapeutics Details
2.9.2 CRISPR Therapeutics Major Business
2.9.3 CRISPR Therapeutics CAR-T Drugs Product and Services
2.9.4 CRISPR Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CRISPR Therapeutics Recent Developments/Updates
2.10 Autolus Therapeutics
2.10.1 Autolus Therapeutics Details
2.10.2 Autolus Therapeutics Major Business
2.10.3 Autolus Therapeutics CAR-T Drugs Product and Services
2.10.4 Autolus Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Autolus Therapeutics Recent Developments/Updates
2.11 Adaptimmune Therapeutics
2.11.1 Adaptimmune Therapeutics Details
2.11.2 Adaptimmune Therapeutics Major Business
2.11.3 Adaptimmune Therapeutics CAR-T Drugs Product and Services
2.11.4 Adaptimmune Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Adaptimmune Therapeutics Recent Developments/Updates
2.12 Atara Biotherapeutics
2.12.1 Atara Biotherapeutics Details
2.12.2 Atara Biotherapeutics Major Business
2.12.3 Atara Biotherapeutics CAR-T Drugs Product and Services
2.12.4 Atara Biotherapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Atara Biotherapeutics Recent Developments/Updates
2.13 Tmunity Therapeutics
2.13.1 Tmunity Therapeutics Details
2.13.2 Tmunity Therapeutics Major Business
2.13.3 Tmunity Therapeutics CAR-T Drugs Product and Services
2.13.4 Tmunity Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Tmunity Therapeutics Recent Developments/Updates
2.14 Iovance Biotherapeutics
2.14.1 Iovance Biotherapeutics Details
2.14.2 Iovance Biotherapeutics Major Business
2.14.3 Iovance Biotherapeutics CAR-T Drugs Product and Services
2.14.4 Iovance Biotherapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Iovance Biotherapeutics Recent Developments/Updates
2.15 Celyad Oncology
2.15.1 Celyad Oncology Details
2.15.2 Celyad Oncology Major Business
2.15.3 Celyad Oncology CAR-T Drugs Product and Services
2.15.4 Celyad Oncology CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Celyad Oncology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CAR-T DRUGS BY MANUFACTURER
3.1 Global CAR-T Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global CAR-T Drugs Revenue by Manufacturer (2018-2023)
3.3 Global CAR-T Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of CAR-T Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 CAR-T Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 CAR-T Drugs Manufacturer Market Share in 2022
3.5 CAR-T Drugs Market: Overall Company Footprint Analysis
3.5.1 CAR-T Drugs Market: Region Footprint
3.5.2 CAR-T Drugs Market: Company Product Type Footprint
3.5.3 CAR-T Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global CAR-T Drugs Market Size by Region
4.1.1 Global CAR-T Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global CAR-T Drugs Consumption Value by Region (2018-2029)
4.1.3 Global CAR-T Drugs Average Price by Region (2018-2029)
4.2 North America CAR-T Drugs Consumption Value (2018-2029)
4.3 Europe CAR-T Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific CAR-T Drugs Consumption Value (2018-2029)
4.5 South America CAR-T Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa CAR-T Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global CAR-T Drugs Sales Quantity by Type (2018-2029)
5.2 Global CAR-T Drugs Consumption Value by Type (2018-2029)
5.3 Global CAR-T Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global CAR-T Drugs Sales Quantity by Application (2018-2029)
6.2 Global CAR-T Drugs Consumption Value by Application (2018-2029)
6.3 Global CAR-T Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America CAR-T Drugs Sales Quantity by Type (2018-2029)
7.2 North America CAR-T Drugs Sales Quantity by Application (2018-2029)
7.3 North America CAR-T Drugs Market Size by Country
7.3.1 North America CAR-T Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America CAR-T Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe CAR-T Drugs Sales Quantity by Type (2018-2029)
8.2 Europe CAR-T Drugs Sales Quantity by Application (2018-2029)
8.3 Europe CAR-T Drugs Market Size by Country
8.3.1 Europe CAR-T Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe CAR-T Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific CAR-T Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific CAR-T Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific CAR-T Drugs Market Size by Region
9.3.1 Asia-Pacific CAR-T Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific CAR-T Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America CAR-T Drugs Sales Quantity by Type (2018-2029)
10.2 South America CAR-T Drugs Sales Quantity by Application (2018-2029)
10.3 South America CAR-T Drugs Market Size by Country
10.3.1 South America CAR-T Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America CAR-T Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa CAR-T Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa CAR-T Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa CAR-T Drugs Market Size by Country
11.3.1 Middle East & Africa CAR-T Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa CAR-T Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 CAR-T Drugs Market Drivers
12.2 CAR-T Drugs Market Restraints
12.3 CAR-T Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of CAR-T Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of CAR-T Drugs
13.3 CAR-T Drugs Production Process
13.4 CAR-T Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 CAR-T Drugs Typical Distributors
14.3 CAR-T Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of CAR-T Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global CAR-T Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 CD19 CAR-T
1.3.3 BCMACAR-T
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global CAR-T Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hematoma
1.4.3 Solid Tumors
1.4.4 Others
1.5 Global CAR-T Drugs Market Size & Forecast
1.5.1 Global CAR-T Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global CAR-T Drugs Sales Quantity (2018-2029)
1.5.3 Global CAR-T Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis CAR-T Drugs Product and Services
2.1.4 Novartis CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR-T Drugs Product and Services
2.2.4 Gilead Sciences CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences Recent Developments/Updates
2.3 WuXi Biologics
2.3.1 WuXi Biologics Details
2.3.2 WuXi Biologics Major Business
2.3.3 WuXi Biologics CAR-T Drugs Product and Services
2.3.4 WuXi Biologics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 WuXi Biologics Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi CAR-T Drugs Product and Services
2.4.4 Sanofi CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi Recent Developments/Updates
2.5 Juno Therapeutics
2.5.1 Juno Therapeutics Details
2.5.2 Juno Therapeutics Major Business
2.5.3 Juno Therapeutics CAR-T Drugs Product and Services
2.5.4 Juno Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Juno Therapeutics Recent Developments/Updates
2.6 Bluebird Bio
2.6.1 Bluebird Bio Details
2.6.2 Bluebird Bio Major Business
2.6.3 Bluebird Bio CAR-T Drugs Product and Services
2.6.4 Bluebird Bio CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bluebird Bio Recent Developments/Updates
2.7 Cellectis
2.7.1 Cellectis Details
2.7.2 Cellectis Major Business
2.7.3 Cellectis CAR-T Drugs Product and Services
2.7.4 Cellectis CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cellectis Recent Developments/Updates
2.8 Precision Biosciences
2.8.1 Precision Biosciences Details
2.8.2 Precision Biosciences Major Business
2.8.3 Precision Biosciences CAR-T Drugs Product and Services
2.8.4 Precision Biosciences CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Precision Biosciences Recent Developments/Updates
2.9 CRISPR Therapeutics
2.9.1 CRISPR Therapeutics Details
2.9.2 CRISPR Therapeutics Major Business
2.9.3 CRISPR Therapeutics CAR-T Drugs Product and Services
2.9.4 CRISPR Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CRISPR Therapeutics Recent Developments/Updates
2.10 Autolus Therapeutics
2.10.1 Autolus Therapeutics Details
2.10.2 Autolus Therapeutics Major Business
2.10.3 Autolus Therapeutics CAR-T Drugs Product and Services
2.10.4 Autolus Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Autolus Therapeutics Recent Developments/Updates
2.11 Adaptimmune Therapeutics
2.11.1 Adaptimmune Therapeutics Details
2.11.2 Adaptimmune Therapeutics Major Business
2.11.3 Adaptimmune Therapeutics CAR-T Drugs Product and Services
2.11.4 Adaptimmune Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Adaptimmune Therapeutics Recent Developments/Updates
2.12 Atara Biotherapeutics
2.12.1 Atara Biotherapeutics Details
2.12.2 Atara Biotherapeutics Major Business
2.12.3 Atara Biotherapeutics CAR-T Drugs Product and Services
2.12.4 Atara Biotherapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Atara Biotherapeutics Recent Developments/Updates
2.13 Tmunity Therapeutics
2.13.1 Tmunity Therapeutics Details
2.13.2 Tmunity Therapeutics Major Business
2.13.3 Tmunity Therapeutics CAR-T Drugs Product and Services
2.13.4 Tmunity Therapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Tmunity Therapeutics Recent Developments/Updates
2.14 Iovance Biotherapeutics
2.14.1 Iovance Biotherapeutics Details
2.14.2 Iovance Biotherapeutics Major Business
2.14.3 Iovance Biotherapeutics CAR-T Drugs Product and Services
2.14.4 Iovance Biotherapeutics CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Iovance Biotherapeutics Recent Developments/Updates
2.15 Celyad Oncology
2.15.1 Celyad Oncology Details
2.15.2 Celyad Oncology Major Business
2.15.3 Celyad Oncology CAR-T Drugs Product and Services
2.15.4 Celyad Oncology CAR-T Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Celyad Oncology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CAR-T DRUGS BY MANUFACTURER
3.1 Global CAR-T Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global CAR-T Drugs Revenue by Manufacturer (2018-2023)
3.3 Global CAR-T Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of CAR-T Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 CAR-T Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 CAR-T Drugs Manufacturer Market Share in 2022
3.5 CAR-T Drugs Market: Overall Company Footprint Analysis
3.5.1 CAR-T Drugs Market: Region Footprint
3.5.2 CAR-T Drugs Market: Company Product Type Footprint
3.5.3 CAR-T Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global CAR-T Drugs Market Size by Region
4.1.1 Global CAR-T Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global CAR-T Drugs Consumption Value by Region (2018-2029)
4.1.3 Global CAR-T Drugs Average Price by Region (2018-2029)
4.2 North America CAR-T Drugs Consumption Value (2018-2029)
4.3 Europe CAR-T Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific CAR-T Drugs Consumption Value (2018-2029)
4.5 South America CAR-T Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa CAR-T Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global CAR-T Drugs Sales Quantity by Type (2018-2029)
5.2 Global CAR-T Drugs Consumption Value by Type (2018-2029)
5.3 Global CAR-T Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global CAR-T Drugs Sales Quantity by Application (2018-2029)
6.2 Global CAR-T Drugs Consumption Value by Application (2018-2029)
6.3 Global CAR-T Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America CAR-T Drugs Sales Quantity by Type (2018-2029)
7.2 North America CAR-T Drugs Sales Quantity by Application (2018-2029)
7.3 North America CAR-T Drugs Market Size by Country
7.3.1 North America CAR-T Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America CAR-T Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe CAR-T Drugs Sales Quantity by Type (2018-2029)
8.2 Europe CAR-T Drugs Sales Quantity by Application (2018-2029)
8.3 Europe CAR-T Drugs Market Size by Country
8.3.1 Europe CAR-T Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe CAR-T Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific CAR-T Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific CAR-T Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific CAR-T Drugs Market Size by Region
9.3.1 Asia-Pacific CAR-T Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific CAR-T Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America CAR-T Drugs Sales Quantity by Type (2018-2029)
10.2 South America CAR-T Drugs Sales Quantity by Application (2018-2029)
10.3 South America CAR-T Drugs Market Size by Country
10.3.1 South America CAR-T Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America CAR-T Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa CAR-T Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa CAR-T Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa CAR-T Drugs Market Size by Country
11.3.1 Middle East & Africa CAR-T Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa CAR-T Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 CAR-T Drugs Market Drivers
12.2 CAR-T Drugs Market Restraints
12.3 CAR-T Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of CAR-T Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of CAR-T Drugs
13.3 CAR-T Drugs Production Process
13.4 CAR-T Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 CAR-T Drugs Typical Distributors
14.3 CAR-T Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global CAR-T Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global CAR-T Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis CAR-T Drugs Product and Services
Table 6. Novartis CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences Major Business
Table 10. Gilead Sciences CAR-T Drugs Product and Services
Table 11. Gilead Sciences CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gilead Sciences Recent Developments/Updates
Table 13. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 14. WuXi Biologics Major Business
Table 15. WuXi Biologics CAR-T Drugs Product and Services
Table 16. WuXi Biologics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. WuXi Biologics Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi CAR-T Drugs Product and Services
Table 21. Sanofi CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sanofi Recent Developments/Updates
Table 23. Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Juno Therapeutics Major Business
Table 25. Juno Therapeutics CAR-T Drugs Product and Services
Table 26. Juno Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Juno Therapeutics Recent Developments/Updates
Table 28. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 29. Bluebird Bio Major Business
Table 30. Bluebird Bio CAR-T Drugs Product and Services
Table 31. Bluebird Bio CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bluebird Bio Recent Developments/Updates
Table 33. Cellectis Basic Information, Manufacturing Base and Competitors
Table 34. Cellectis Major Business
Table 35. Cellectis CAR-T Drugs Product and Services
Table 36. Cellectis CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cellectis Recent Developments/Updates
Table 38. Precision Biosciences Basic Information, Manufacturing Base and Competitors
Table 39. Precision Biosciences Major Business
Table 40. Precision Biosciences CAR-T Drugs Product and Services
Table 41. Precision Biosciences CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Precision Biosciences Recent Developments/Updates
Table 43. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. CRISPR Therapeutics Major Business
Table 45. CRISPR Therapeutics CAR-T Drugs Product and Services
Table 46. CRISPR Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. CRISPR Therapeutics Recent Developments/Updates
Table 48. Autolus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 49. Autolus Therapeutics Major Business
Table 50. Autolus Therapeutics CAR-T Drugs Product and Services
Table 51. Autolus Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Autolus Therapeutics Recent Developments/Updates
Table 53. Adaptimmune Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. Adaptimmune Therapeutics Major Business
Table 55. Adaptimmune Therapeutics CAR-T Drugs Product and Services
Table 56. Adaptimmune Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Adaptimmune Therapeutics Recent Developments/Updates
Table 58. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 59. Atara Biotherapeutics Major Business
Table 60. Atara Biotherapeutics CAR-T Drugs Product and Services
Table 61. Atara Biotherapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Atara Biotherapeutics Recent Developments/Updates
Table 63. Tmunity Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Tmunity Therapeutics Major Business
Table 65. Tmunity Therapeutics CAR-T Drugs Product and Services
Table 66. Tmunity Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Tmunity Therapeutics Recent Developments/Updates
Table 68. Iovance Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 69. Iovance Biotherapeutics Major Business
Table 70. Iovance Biotherapeutics CAR-T Drugs Product and Services
Table 71. Iovance Biotherapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Iovance Biotherapeutics Recent Developments/Updates
Table 73. Celyad Oncology Basic Information, Manufacturing Base and Competitors
Table 74. Celyad Oncology Major Business
Table 75. Celyad Oncology CAR-T Drugs Product and Services
Table 76. Celyad Oncology CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Celyad Oncology Recent Developments/Updates
Table 78. Global CAR-T Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global CAR-T Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global CAR-T Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in CAR-T Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and CAR-T Drugs Production Site of Key Manufacturer
Table 83. CAR-T Drugs Market: Company Product Type Footprint
Table 84. CAR-T Drugs Market: Company Product Application Footprint
Table 85. CAR-T Drugs New Market Entrants and Barriers to Market Entry
Table 86. CAR-T Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global CAR-T Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global CAR-T Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global CAR-T Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global CAR-T Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global CAR-T Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global CAR-T Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global CAR-T Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global CAR-T Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global CAR-T Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global CAR-T Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global CAR-T Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global CAR-T Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global CAR-T Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global CAR-T Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America CAR-T Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America CAR-T Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America CAR-T Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America CAR-T Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe CAR-T Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe CAR-T Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe CAR-T Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe CAR-T Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific CAR-T Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific CAR-T Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific CAR-T Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific CAR-T Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America CAR-T Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America CAR-T Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America CAR-T Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America CAR-T Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa CAR-T Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa CAR-T Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa CAR-T Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa CAR-T Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 145. CAR-T Drugs Raw Material
Table 146. Key Manufacturers of CAR-T Drugs Raw Materials
Table 147. CAR-T Drugs Typical Distributors
Table 148. CAR-T Drugs Typical Customers
LIST OF FIGURE
s
Figure 1. CAR-T Drugs Picture
Figure 2. Global CAR-T Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global CAR-T Drugs Consumption Value Market Share by Type in 2022
Figure 4. CD19 CAR-T Examples
Figure 5. BCMACAR-T Examples
Figure 6. Others Examples
Figure 7. Global CAR-T Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global CAR-T Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hematoma Examples
Figure 10. Solid Tumors Examples
Figure 11. Others Examples
Figure 12. Global CAR-T Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global CAR-T Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global CAR-T Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global CAR-T Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global CAR-T Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global CAR-T Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of CAR-T Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 CAR-T Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 CAR-T Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global CAR-T Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global CAR-T Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global CAR-T Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. Global CAR-T Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global CAR-T Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global CAR-T Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America CAR-T Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America CAR-T Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe CAR-T Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe CAR-T Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific CAR-T Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific CAR-T Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America CAR-T Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America CAR-T Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa CAR-T Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa CAR-T Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. CAR-T Drugs Market Drivers
Figure 75. CAR-T Drugs Market Restraints
Figure 76. CAR-T Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of CAR-T Drugs in 2022
Figure 79. Manufacturing Process Analysis of CAR-T Drugs
Figure 80. CAR-T Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Table 1. Global CAR-T Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global CAR-T Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis CAR-T Drugs Product and Services
Table 6. Novartis CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences Major Business
Table 10. Gilead Sciences CAR-T Drugs Product and Services
Table 11. Gilead Sciences CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gilead Sciences Recent Developments/Updates
Table 13. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 14. WuXi Biologics Major Business
Table 15. WuXi Biologics CAR-T Drugs Product and Services
Table 16. WuXi Biologics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. WuXi Biologics Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi CAR-T Drugs Product and Services
Table 21. Sanofi CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sanofi Recent Developments/Updates
Table 23. Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Juno Therapeutics Major Business
Table 25. Juno Therapeutics CAR-T Drugs Product and Services
Table 26. Juno Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Juno Therapeutics Recent Developments/Updates
Table 28. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 29. Bluebird Bio Major Business
Table 30. Bluebird Bio CAR-T Drugs Product and Services
Table 31. Bluebird Bio CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bluebird Bio Recent Developments/Updates
Table 33. Cellectis Basic Information, Manufacturing Base and Competitors
Table 34. Cellectis Major Business
Table 35. Cellectis CAR-T Drugs Product and Services
Table 36. Cellectis CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cellectis Recent Developments/Updates
Table 38. Precision Biosciences Basic Information, Manufacturing Base and Competitors
Table 39. Precision Biosciences Major Business
Table 40. Precision Biosciences CAR-T Drugs Product and Services
Table 41. Precision Biosciences CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Precision Biosciences Recent Developments/Updates
Table 43. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. CRISPR Therapeutics Major Business
Table 45. CRISPR Therapeutics CAR-T Drugs Product and Services
Table 46. CRISPR Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. CRISPR Therapeutics Recent Developments/Updates
Table 48. Autolus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 49. Autolus Therapeutics Major Business
Table 50. Autolus Therapeutics CAR-T Drugs Product and Services
Table 51. Autolus Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Autolus Therapeutics Recent Developments/Updates
Table 53. Adaptimmune Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. Adaptimmune Therapeutics Major Business
Table 55. Adaptimmune Therapeutics CAR-T Drugs Product and Services
Table 56. Adaptimmune Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Adaptimmune Therapeutics Recent Developments/Updates
Table 58. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 59. Atara Biotherapeutics Major Business
Table 60. Atara Biotherapeutics CAR-T Drugs Product and Services
Table 61. Atara Biotherapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Atara Biotherapeutics Recent Developments/Updates
Table 63. Tmunity Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Tmunity Therapeutics Major Business
Table 65. Tmunity Therapeutics CAR-T Drugs Product and Services
Table 66. Tmunity Therapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Tmunity Therapeutics Recent Developments/Updates
Table 68. Iovance Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 69. Iovance Biotherapeutics Major Business
Table 70. Iovance Biotherapeutics CAR-T Drugs Product and Services
Table 71. Iovance Biotherapeutics CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Iovance Biotherapeutics Recent Developments/Updates
Table 73. Celyad Oncology Basic Information, Manufacturing Base and Competitors
Table 74. Celyad Oncology Major Business
Table 75. Celyad Oncology CAR-T Drugs Product and Services
Table 76. Celyad Oncology CAR-T Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Celyad Oncology Recent Developments/Updates
Table 78. Global CAR-T Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global CAR-T Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global CAR-T Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in CAR-T Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and CAR-T Drugs Production Site of Key Manufacturer
Table 83. CAR-T Drugs Market: Company Product Type Footprint
Table 84. CAR-T Drugs Market: Company Product Application Footprint
Table 85. CAR-T Drugs New Market Entrants and Barriers to Market Entry
Table 86. CAR-T Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global CAR-T Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global CAR-T Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global CAR-T Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global CAR-T Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global CAR-T Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global CAR-T Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global CAR-T Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global CAR-T Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global CAR-T Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global CAR-T Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global CAR-T Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global CAR-T Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global CAR-T Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global CAR-T Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America CAR-T Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America CAR-T Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America CAR-T Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America CAR-T Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe CAR-T Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe CAR-T Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe CAR-T Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe CAR-T Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific CAR-T Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific CAR-T Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific CAR-T Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific CAR-T Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America CAR-T Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America CAR-T Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America CAR-T Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America CAR-T Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa CAR-T Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa CAR-T Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa CAR-T Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa CAR-T Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa CAR-T Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa CAR-T Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa CAR-T Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa CAR-T Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 145. CAR-T Drugs Raw Material
Table 146. Key Manufacturers of CAR-T Drugs Raw Materials
Table 147. CAR-T Drugs Typical Distributors
Table 148. CAR-T Drugs Typical Customers
LIST OF FIGURE
s
Figure 1. CAR-T Drugs Picture
Figure 2. Global CAR-T Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global CAR-T Drugs Consumption Value Market Share by Type in 2022
Figure 4. CD19 CAR-T Examples
Figure 5. BCMACAR-T Examples
Figure 6. Others Examples
Figure 7. Global CAR-T Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global CAR-T Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hematoma Examples
Figure 10. Solid Tumors Examples
Figure 11. Others Examples
Figure 12. Global CAR-T Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global CAR-T Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global CAR-T Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global CAR-T Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global CAR-T Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global CAR-T Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of CAR-T Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 CAR-T Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 CAR-T Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global CAR-T Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global CAR-T Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa CAR-T Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global CAR-T Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. Global CAR-T Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global CAR-T Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global CAR-T Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America CAR-T Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America CAR-T Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe CAR-T Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe CAR-T Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific CAR-T Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific CAR-T Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America CAR-T Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America CAR-T Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa CAR-T Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa CAR-T Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa CAR-T Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa CAR-T Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa CAR-T Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. CAR-T Drugs Market Drivers
Figure 75. CAR-T Drugs Market Restraints
Figure 76. CAR-T Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of CAR-T Drugs in 2022
Figure 79. Manufacturing Process Analysis of CAR-T Drugs
Figure 80. CAR-T Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
